Characterization of multinucleated giant cells in synovium and subchondral bone in knee osteoarthritis and rheumatoid arthritis

BMC Musculoskeletal Disorders

Volumn 16, Issue 1, 2015, Pages

  Prieto Potin, Iván ^a   Largo, Raquel ^a   Roman Blas, Jorge A ^a   Herrero Beaumont, Gabriel ^a   Walsh, David A ^b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CATHEPSIN K; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GLUCOCORTICOID; HYDROXYCHLOROQUINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RITUXIMAB; SALAZOSULFAPYRIDINE; VITAMIN D; ACID PHOSPHATASE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ANTIRHEUMATIC AGENT; BIOLOGICAL MARKER; CTSK PROTEIN, HUMAN; ISOENZYME;

ADIPOCYTE; ADULT; AGED; ARTICLE; AUTOPSY; CELL COUNT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOAM LIKE GIANT CELL; GIANT CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KNEE OSTEOARTHRITIS; LANGHANS GIANT CELL; MAJOR CLINICAL STUDY; MALE; OSTEOCLAST; PATHOGENESIS; PLASMA LIKE GIANT CELL; RHEUMATOID ARTHRITIS; SYNOVITIS; SYNOVIUM; TOTAL KNEE REPLACEMENT; ARTHRITIS, RHEUMATOID; CHEMISTRY; CLASSIFICATION; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; KNEE; MACROPHAGE; METHODOLOGY; MIDDLE AGED; OSTEOARTHRITIS; PATHOLOGY; SINGLE BLIND PROCEDURE; TIBIA; ULTRASTRUCTURE;

ACID PHOSPHATASE; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOMARKERS; CALCIUM; CATHEPSIN K; CROSS-SECTIONAL STUDIES; DIPHOSPHONATES; FEMALE; GIANT CELLS; GIANT CELLS, LANGHANS; GLUCOCORTICOIDS; HUMANS; ISOENZYMES; KNEE JOINT; MACROPHAGES; MALE; MIDDLE AGED; OSTEOARTHRITIS; OSTEOCLASTS; RESEARCH DESIGN; SINGLE-BLIND METHOD; SYNOVIAL MEMBRANE; TARTRATE-RESISTANT ACID PHOSPHATASE; TIBIA; VITAMIN D;

EID: 84940178164     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/s12891-015-0664-5     Document Type: Article

References (59)

1. Stoppiello LA, Mapp PI, Wilson D, Scammell BE, Orth F, Walsh DA. Structural associations of symptomatic knee osteoarthritis. Arthritis Rheum. 2014;66:3018-27.
2. Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012;64:1697-707.
3. Woolley DE, Tetlow LC. Observations on the microenvironmental nature of cartilage degradation in rheumatoid arthritis. Ann Rheum Dis. 1997;56:151-61.
4. Benito M, Veale D, FitzGerald O, Van den Berg W, Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis. 2005;64:1263-7.
5. Ayral X, Pickering EH, Woodworth TG, Mackillop N, Dougados M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis - results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage. 2005;13:361-7.
6. Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone. 2012;51:249-57.
7. Walsh DA, McWilliams DF, Turley MJ, Dixon MR, Fransès RE, Mapp PI, et al. Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis. Rheumatology (Oxford). 2010;49:1852-61.
8. Mulherin D, Fitzgerald O, Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum. 1996;39:115-24.
9. Anderson JM. Multinucleated giant cells. Curr Opin Hematol. 2000;7:40-7.
10. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20:86-100.
11. Cowan RW, Singh G. Giant cell tumor of bone: A basic science perspective. Bone. 2012;52:238-46.
12. Khan UA, Hashimi SM, Khan S, Quan J, Bakr MM, Forwood MR, et al. Differential expression of chemokines, chemokine receptors and proteinases by foreign body giant cells (FBGCs) and osteoclasts. J Cell Biochem. 2014;115:1290-8.
13. Maggiani F, Forsyth R, Hogendoorn PCW, Krenacs T, Athanasou NA. The immunophenotype of osteoclasts and macrophage polykaryons. J Clin Pathol. 2011;64:701-5.
14. Quinn MT, Schepetkin IA. Role of NADPH oxidase in formation and function of multinucleated giant cells. J Innate Immun. 2009;1:509-26.
15. Lay G, Poquet Y, Puissegur M, Botanch C, Bon H, Levillain F, et al. Langhans giant cells from M. tuberculosis -induced human granulomas cannot mediate mycobacterial uptake. J Pathol. 2007;211:76-85.
16. Brodbeck WG, Anderson JM. Giant cell formation and function. Curr Opin Hematol. 2009;16:53-7.
17. Gómez-Mateo MDC, Monteagudo C. Nonepithelial skin tumors with multinucleated giant cells. Semin Diagn Pathol. 2013;30:58-72.
18. Schett G. Cells of the synovium in rheumatoid arthritis. Osteoclasts. Arthritis Res Ther. 2007;9:203.
19. Bhan AK, Roy S. Synovial giant cells in rheumatoid arthritis and other joint diseases. Ann Rheum Dis. 1971;30:294-8.
20. Soren A, Waugh TR. The giant cells in the synovial membrane. Ann Rheum Dis. 1981;40:496-500.
21. Grimley P, Sokoloff L. Synovial giant cells in rheumatoid arthritis. Am J Pathol. 1966;49:931-54.
22. Ogawa K, Mawatari M, Komine M, Shigematsu M, Kitajima M, Kukita A, et al. Mature and activated osteoclasts exist in the synovium of rapidly destructive coxarthrosis. J Bone Miner Metab. 2007;25:354-60.
23. Seitz S, Zustin J, Amling M, Rüther W, Niemeier A. Massive accumulation of osteoclastic giant cells in rapid destructive hip disease. J Orthop Res. 2014;32:702-8.
24. Ashton BA, Ashton IK, Marshall MJ, Butler RC. Localisation of vitronectin receptor immunoreactivity and tartrate resistant acid phosphatase activity in synovium from patients with inflammatory or degenerative arthritis. Ann Rheum Dis. 1993;52:133-7.
25. Wilkinson LS, Pitsillides AA, Edwards JC. Giant cells in arthritic synovium. Ann Rheum Dis. 1993;52:182-4.
26. Rousseau JC, Garnero P. Biological markers in osteoarthritis. Bone. 2012;51:265-77.
27. Woloszynski T, Podsiadlo P, Stachowiak GW, Kurzynski M, Lohmander LS, Englund M. Prediction of progression of radiographic knee osteoarthritis using tibial trabecular bone texture. Arthritis Rheum. 2012;64:688-95.
28. Hunter DJ. Insights from Imaging on the Epidemiology and Pathophysiology of Osteoarthritis. Radiol Clin North Am. 2009;47(4):539-51.
29. Roman-Blas JA, Castañeda S, Largo R, Lems WF, Herrero-Beaumont G. An OA phenotype may obtain major benefit from bone-acting agents. Semin Arthritis Rheum. 2014;43:421-8.
30. Bucklandwright C. Subchondral bone changes in hand and knee osteoarthritis detected by radiography. Osteoarthr Cartil. 2004;12:10-9.
31. Sagar DR, Ashraf S, Xu L, Burston JJ, Menhinick MR, Poulter CL, Bennett AJ, Walsh DA, Chapman V: Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis. Ann rheum Dis 2013 [Epub ahead of print].
32. Bugatti S, Caporali R, Manzo A, Vitolo B, Pitzalis C, Montecucco C. Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitment. Arthritis Rheum. 2005;52:3448-59.
33. Schett G, Stolina M, Bolon B, Middleton S, Adlam M, Brown H, et al. Analysis of the kinetics of osteoclastogenesis in arthritic rats. Arthritis Rheum. 2005;52:3192-201.
34. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum. 1986;29:1039-49.
35. Arnett F, Edworthy S, Bloch D. The american rheumatism association 1987 revised criteria for the classification of the rheumatoid arthritis. Arthritis Rheum. 1988;31:315-24.
36. Fransen J, van Riel PLCM. The Disease Activity Score and the EULAR response criteria. Clin Exp Rheumatol. 2005;23(5 Suppl 39):S93-9.
37. Haywood L, McWilliams DF, Pearson CI, Gill SE, Ganesan A, Wilson D, et al. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum. 2003;48:2173-7.
38. Krenn V, Morawietz L, Häupl T, Neidel J, Petersen I, König A. Grading of chronic synovitis - a histopathological grading system for molecular and diagnostic pathology. Pathol Res Pract. 2002;198:317-25.
39. Perry M, Mustafa Y, Wood S, Cawley M. Binucleated and multinucleated forms of plasma cells in synovia from patients with rheumatoid arthritis. Rheumatol Int. 1997;17:169-74.
40. Shu SY, Ju G, Fan LZ. The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett. 1988;85:169-71.
41. Park JK, Rosen A, Saffitz JE, Asimaki A, Litovsky SH, Mackey-Bojack SM, et al. Expression of cathepsin K and tartrate-resistant acid phosphatase is not confined to osteoclasts but is a general feature of multinucleated giant cells: systematic analysis. Rheumatology (Oxford). 2013;52:1529-33.
42. Wenham CYJ, Conaghan PG. The role of synovitis in osteoarthritis. Ther Adv Musculoskelet Dis. 2010;2:349-59.
43. Walsh DA, Yousef A, McWilliams DF, Hill R, Hargin E, Wilson D. Evaluation of a Photographic Chondropathy Score (PCS) for pathological samples in a study of inflammation in tibiofemoral osteoarthritis. Osteoarthritis Cartilage. 2009;17:304-12.
44. Koizumi F, Matsuno H, Wakaki K, Ishii Y, Kurashige Y, Nakamura H. Synovitis in rheumatoid arthritis: scoring of characteristic histopathological features. Pathol Int. 1999;49:298-304.
45. Scanzello CR, Plaas A, Crow MK. Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound? Curr Opin Rheumatol. 2008;20(5):565-72.
46. Gómez R, Villalvilla A, Largo R, Gualillo O, Herrero-Beaumont G: TLR4 signalling in osteoarthritis-finding targets for candidate DMOADs. Nat Rev Rheumatol 2015;11(3):159-70.
47. De Lange-Brokaar BJE, Ioan-Facsinay A, van Osch GJVM, Zuurmond A, Schoones J, Toes REM, et al. Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review. Osteoarthritis Cartilage. 2012;20:1484-99.
48. Consolaro A, Sant'Ana E, Lawall MA, Consolaro MFMO, Bacchi CE. Gingival juvenile xanthogranuloma in an adult patient: case report with immunohistochemical analysis and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107:246-52.
49. Aterman K, Remmele W, Smith M. Karl Touton and His "Xanthelasmatic Giant Cell" A Selective Review of Multinucleated Giants Cells. Am J Dermatopathol. 1988;10:257-69.
50. Ferraz-Amaro I, González-Juanatey C, López-Mejias R, Riancho-Zarrabeitia L, González-Gay MA. Metabolic syndrome in rheumatoid arthritis. Mediators Inflamm. 2013;2013:11.
51. Prieto-Potin I, Roman-Blas JA, Martinez-Calatrava MJ, Gomez R, Largo R, Herrero-Beaumont G. Hypercholesterolemia boosts joint destruction in chronic arthritis. An experimental model aggravated by foam macrophage infiltration. Arthritis Res Ther. 2013;15:R81.
52. Connor JR, Dodds RA, James IE, Gowen M. Human osteoclast and giant cell differentiation: the apparent switch from nonspecific esterase to tartrate resistant acid phosphatase activity coincides with the in situ expression of osteopontin mRNA. J Histochem Cytochem. 1995;43:1193-201.
53. Jösten M, Rudolph R. Methods for the differentiation of giant cells in canine and feline neoplasias in paraffin sections. Zentralbl Vet A. 1997;44:630.
54. Park JK, Askin F, Giles JT, Halushka MK, Rosen A, Levine SM. Increased generation of TRAP expressing multinucleated giant cells in patients with granulomatosis with polyangiitis. PLoS One. 2012;7:e42659.
55. Nordborg E, Bengtsson B, Petursdottir V, Nordborg C. Morphological aspects of giant cells in giant cell arteritis: an electron-microscopic and immunocytochemical study. Clin Exp Rheumatol. 1997;15:129-34.
56. Shibakawa A, Yudoh K, Masuko-Hongo K, Kato T, Nishioka K, Nakamura H. The role of subchondral bone resorption pits in osteoarthritis: MMP production by cells derived from bone marrow. Osteoarthr Cartil. 2005;13:679-87.
57. Knowles HJ, Moskovsky L, Thompson MS, Grunhen J, Cheng X, Kashima TG, et al. Chondroclasts are mature osteoclasts which are capable of cartilage matrix resorption. Virchows Arch. 2012;461:205-10.
58. Karsdal MA, Bay-Jensen AC, Lories RJ, Abramson S, Spector T, Pastoureau P, et al. The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments? Ann Rheum Dis. 2014;73:336-48.
59. Botter SM, van Osch GJVM, Clockaerts S, Waarsing JH, Weinans H, van Leeuwen JPTM. Osteoarthritis induction leads to early and temporal subchondral plate porosity in the tibial plateau of mice: An in vivo micro CT study. Arthritis Rheum. 2011;63:2690-9.